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Abstract
Gonorrhea is one of the most prevalent sexually transmitted diseases in the world. A naturally occurring variation of the
terminal carbohydrates on the lipooligosaccharide (LOS) molecule correlates with altered disease states. Here, we
investigated the interaction of different stable gonoccocal LOS phenotypes with human dendritic cells and demonstrate
that each variant targets a different set of receptors on the dendritic cell, including the C-type lectins MGL and DC-SIGN.
Neisseria gonorrhoeae LOS phenotype C constitutes the first bacterial ligand to be described for the human C-type lectin
receptor MGL. Both MGL and DC-SIGN are locally expressed at the male and female genital area, the primary site of N.
gonorrhoeae infection. We show that targeting of different C-type lectins with the N. gonorrhoeae LOS variants results in
alterations in dendritic cell cytokine secretion profiles and the induction of distinct adaptive CD4+ T helper responses.
Whereas N. gonorrhoeae variant A with a terminal N-acetylglucosamine on its LOS was recognized by DC-SIGN and induced
significantly more IL-10 production, phenotype C, carrying a terminal N-acetylgalactosamine, primarily interacted with MGL
and skewed immunity towards the T helper 2 lineage. Together, our results indicate that N. gonorrhoeae LOS variation
allows for selective manipulation of dendritic cell function, thereby shifting subsequent immune responses in favor of
bacterial survival.
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Introduction
Neisseria gonorrhoeae (gonococci, GC) is the causative agent of
gonorrhea, one of the main sexually transmitted diseases. Global
incidence has been estimated at 62 million infected people
annually [1]. Although gonorrhea can remain asymptomatic,
complications of the disease include pelvic inflammatory disease
with a subsequent risk of infertility, and invasive and potentially
life-threatening disseminated gonoccocal infection. Furthermore,
gonorrhea is believed to predispose individuals to HIV-1 and
Chlamydia trachomatis infection [2,3].
GC colonize and invade the genital mucosal sites. The
interaction between GC and the epithelial layer has been well
characterized and involves the interaction of several GC virulence
factors, including pili, porin and Opa proteins, to their respective
receptors. Whereas GC pili may adhere to CD46 [4], the PorB
porin attaches to heat shock protein Gp96 and the scavenger
receptor SREC [5]. The opacity (Opa) proteins are divided into
two major classes which adhere to either syndecans or CD66
family members [6].
After traversion of the epithelial cell barrier GC enter the
submucosa, where they first encounter cells of the immune system,
such as dendritic cells (DCs). DCs are the most potent antigen
presenting cells of the immune system, capable of linking innate
and adaptive immune responses [7,8]. Immature DCs reside in all
peripheral tissues where they act as sentinels to screen their
surroundings for incoming pathogens. Upon microbial encounter
immature DCs undergo a transitional process termed maturation,
which involves migration to draining lymph nodes, upregulation of
costimulatory molecules and the secretion of pro-inflammatory
cytokines. In the lymph node mature DCs activate naı¨ve T cells,
thereby inducing adaptive immunity. In contrast to GC-epithelial
interaction, little is known about the recognition of GC by DCs.
To detect pathogens DCs are equipped with a vast array of pattern
recognition receptors (PPRs), including the Toll-like receptors (TLRs)
and the C-type lectin receptors (C-type lectins) [9,10]. In contrast to
lipopolysaccharides (LPS) from enteric bacteria, GC express
lipooligosaccharide (LOS), lacking the O-antigen. LOS can act as a
GC virulence factor through recognition of its lipid A part by TLR-
4/MD2 complex. The carbohydrate moiety of GC LOS is subject to
phase variation, creating a GC population with different terminal
carbohydrate residues on their LOS [11,12]. These carbohydrate
moieties may serve as ligands for sugar-dependent receptors, such as
the C-type lectin DC-SIGN. Increasing evidence indicates that TLR
and C-type lectin signaling cooperate and influence each other,
thereby ensuing and controlling immune responses [13,14]. Thus,
variation of the terminal sugar of GC LOS could have a major
impact on how GC modulates DC function.
We investigated three well-defined GC variants (Figure 1A),
which only differ in their terminal LOS glycosylation [15], on DC
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recognition and their immunomodulatory properties. These
variants are derived from GC strain F62 that contains LOS with
mainly terminal N-acetylgalactosamine (GalNAc) residues. After
inactivation of the glycosyltransferases genes lgtD and lgtB stable
LOS variants were obtained that exhibit a terminal galactose and
N-acetylglucosamine (GlcNAc), respectively. In vivo this variation
occurs via slipped-stand mispairing of polynucleotide tracts within
the lgtD gene, leading to exposure of a terminal GalNAc when the
lgtD gene is functionally present and a terminal galactose residue
when the gene is switched off [16]. The terminal galactose can
serve as substrates for a2-3-sialylation rendering the bacteria
resistant to complement killing [17,18]. Thus, modification of the
terminal galactose moiety appears to be of vital importance to the
bacteria to subvert host defense systems.
Already in 1991 Schneider et al. demonstrated that when
healthy volunteers were challenged with GC strain MS11 variant
A (equivalent to the F62 variant B used in this study) the majority
of the recovered variants expressed variant C (equivalent to F62
phenotype C) [19]. Their results indicate that GC LOS variants
containing a terminal GalNAc residue have a selective advantage
compared to variants ending in a terminal galactose. GC with
phenotype C may have an enhanced ability to colonize or colonize
epithelial cells, but may also posses immune evasive properties that
explain the preferential outgrowth of this variant.
Here we demonstrate that the C-type lectin macrophage
galactose-type lectin (MGL) is the DC-expressed receptor for N.
gonorrhoeae strain F62 phenotype C and that recognition of the B
variant is not C-type lectin-mediated. Furthermore, we confirm
and extend on previous findings showing that the C-type lectin
Author Summary
Neisseria gonorrhoeae is a species of Gram-negative
bacteria responsible for the sexually transmitted disease
gonorrhea. Although effective antibiotic treatments are
available, little is known about the host immune response
to this pathogen. Here, we analyzed three well-character-
ized gonococcal variants that only differ in the outer sugar
present on the lipooligosaccharide of the bacteria. We
found that human dendritic cells use different receptors,
including the C-type lectins MGL and DC-SIGN, to detect
the three N. gonorrhoeae phenotypes. Dendritic cells
carrying the MGL and DC-SIGN receptor were present in
the human genital tissues, the site of gonoccocal invasion.
DC activation with the gonococcal variants resulted in
different cytokine secretion profiles and alterations in the
subsequent adaptive T cell response. In particular, LOS
containing a terminal N-acetylgalactosamine induced
more T helper 2-type responses, which are unfavorable
for clearing the bacteria. Our data provide new insights
into the pathogenesis of N. gonorrhoeae and suggest that
variation of lipooligosaccharide glycosylation enables to
bacteria to selectively subvert host immune defense
mechanisms.
Figure 1. Characteristics of the N. gonorrhoeae F62 LOS phenotypes. (A) Schematic representation of the LOS strucuture of theisogenic LOS
mutants of GC F62 (phenotype C) and its derivatives D3 (phenotype B) and I3 (phenotype A) that contain deletions within the glycosyltransferase
genes lgtD and lgtB respectively. Figure adapted from [15]. (B) LOS silverstaining of tricine SDS-PAGE separated proteinase K digests of the different
F62 phenotypes. (C) Western blot of whole cell lysates of the F62 variants incubated with the Opa-protein specific monoclonal antibody 4B12/CII. A
lysate of the Opa-expressing strain N. gonorrhoeae strain VP1 served as a positive control.
doi:10.1371/journal.ppat.1000625.g001
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DC-SIGN interacts with the GC variant A [20,21]. Although all
GC variants induced equal DC maturation, phenotypic differences
in the DC cytokines profiles and subsequent T cell polarization
were observed based on the differential C-type lectin usage of the
GC phase variants. Together these results provide a possible
molecular mechanism contributing to the reported in vivo GC
behavior [19] and indicate that variation of the GC LOS
glycosylation interferes with the hosts ability to eradicate this
pathogen.
Results
GC LOS glycosylation variants differentially interact with
human DCs
To study the immunogenicity of GC that differ in their terminal
LOS structure, we employed three well-characterized and stable
non-piliated N. gonorrhoeae F62 variants [15]. The representative
LOS glycan structures are depicted in Figure 1A. Variant B lacks
the terminal GalNAc found in the F62 phenotype C and instead
displays a terminal galactose. Variant A carries a terminal GlcNAc
residue. Tricine SDS-PAGE confirmed the reported electropho-
retic mobility of the LOS variants (Figure 1B). Phenotype C carries
mainly LOS with a terminal GalNAc residue and a minor
component with a terminal Gal residue [22,23]. Western blotting
of the variants showed equal Opa protein-negative phenotypes,
excluding GC interactions with CD66 receptors (Figure 1C).
Bacteria were FITC-labeled to assess their interaction with
human immature DC (Figure S1). Incubation of immature DC
with the GC variants with the different LOS phenotypes at
different bacteria: DC ratios yielded high level binding for variant
A, intermediate binding levels for phenotype C and the lowest
binding for the B variant (Figure 2A). These differences in
interaction were mainly visible at prolonged incubation times of 1
and 2 hours (Figure 2A). Bacterial phagocytosis was analyzed by
flow cytometry in the presence of trypan blue. Trypan blue
quenches all extracellular fluorescence, allowing for the measure-
ment of intracellular bacteria. All variants were phagocytosed at
similar kinetics as observed in the binding experiments (Figure 2B
and two additional donors in Figure S2), indicating that
phagocytosis rate is largely determined by the total number of
bacteria bound to the DC. In the presence of cytochalasin D (Cyt
D), a known inhibitor of actin polymerization, phagocytosis of
fixed GC was significantly blocked after 1 hour incubation,
proving that the DCs actually internalized the GC (Figure 2C).
Similar results were obtained after 2 hours of phagocytosis (data
not shown). Our results with fixed GC were confirmed using live
GC phenotypes, which were also bound by immature DC in a
dose-dependent manner (Figure 2D). Similar to fixed GC, live GC
of phenotype A bound at higher levels than variant C. Live GC of
variant B showed the weakest binding to immature DCs.
To investigate the nature of the DC receptors involved, binding
experiments were performed in the presence of the Ca2+-chelator
EGTA, a well-known blocker of C-type lectin function. Binding of
fixed GC phenotypes A and C was largely Ca2+-dependent and
thus likely mediated by C-type lectins (Figure 2E, left panel). The
residual binding, equivalent to variant B binding levels, could not
be blocked by EGTA and may be conferred by other non-C-type
lectin receptors. The addition of free GalNAc, but not control
glucose monosaccharides reduced N. gonorhoeae phenotype C
binding to variant B levels, indicating that a GalNAc-specific C-
type lectin is responsible for binding of variant C (Figure 2E, left
panel). Similar results were obtained for live FITC-labeled GC of
phenotype C (Figure 2E, right panel).
The C-type lectin MGL is a receptor for Neisseria
gonorrhoeae phenotype C
One possible candidate C-type lectin is the asialoglycoprotein
receptor (ASGP-R) which has a known specificity for galactose/
GalNAc and is present on urethral epithelial cells where it
facilitates entry of GC that express the complementary glycan
structures [24]. However, this C-type lectin is not expressed on
DCs. DCs do express the GalNAc-specific C-type lectin MGL
[25]. We hypothesized that this lectin might be the major receptor
for GC phenotype C.
A fusion protein of the extracellular domains of MGL coupled
to the human IgG1 Fc tail strongly recognized GC variant C in a
dose-dependent manner in an ELISA-based assay (Figure 3A).
MGL-Fc also directly bound to purified LOS from variant C
(Figure 3C). In contrast, GC and LOS from variants A and B only
bound at background levels. MGL-Fc binding to GC phenotype C
or purified LOS derived from this variant was blocked by the
addition of the Ca2+-chelator EGTA, free GalNAc monosaccha-
rides and anti-MGL antibodies, but not by glucose or isotype
control antibodies, confirming the specificity of this interaction
(Figure 3B and 3C).
Next, we investigated the recognition of GC phenotype C by
cells that express the MGL protein, such as CHO-MGL
transfectants and human monocyte-derived DCs (Figures 3D
and 3G). CHO-MGL cells bound GC variant C with high affinity
in a dose-dependent manner, while variant A adhered at low level
and variant B was not recognized (Figure 3E). The interaction of
MGL with GC phenotype C was specific, as shown by the
inhibitory action of EGTA, free GalNAc monosaccharides and
anti-MGL antibodies (Figure 3F). Immature DCs expressed both
the C-type lectins MGL and DC-SIGN (Figure 3G). Binding of
GC variant C to DCs was blocked to variant B levels using specific
anti-MGL antibodies, whereas binding of phenotype A was
inhibited by pretreating the DCs with anti-DC-SIGN antibodies
or the DC-SIGN ligand mannan (Figure 3H and [20,21]).
Although we observed some residual binding of CHO-MGL to
variant A (Figure 3F), in DCs binding of this phenotype was
largely DC-SIGN-mediated. The residual binding is probably
independent of the LOS carbohydrate variation as all variants
bind equally well to DC after inhibiting C-type lectin function.
Thus, immature DCs interact with GC variants C and A mainly
through the lectins MGL and DC-SIGN, respectively.
MGL and DC-SIGN expressing cells are present in male
and female genital tissues
If the C-type lectins MGL and DC-SIGN are physiological
important receptors that play an active role in the pathogenesis of
GC, these proteins should be expressed at the site of GC entry, the
female cervix and the male penile urethral tissue. DC-SIGNpos
cells have been shown to be present in cervix [26], however it is
currently unclear whether MGLpos cells are located there as well.
Therefore, we stained healthy human urethra and cervix with
antibodies to DC-SIGN and MGL. MGLpos cells were clearly
visible just beneath and in the epithelial layers of both tissues
(Figure 4). These results are in contrast to human skin, where
MGLpos cells are exclusively localized in the dermis [27]. A subset
of the MGLpos cells in the cervix co-expressed the marker CD1a
(data not shown), confirming this subset to be DCs. DC-SIGN
expression was confined to the sub-epithelium on a subset of cells
that did not co-express the MGL molecule. Thus, both MGL and
DC-SIGN were expressed at the site of GC entry and could thus
participate in the recognition of this pathogen by local antigen
presenting cells.
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Figure 2. Differential binding of GC glycosylation variants to DCs. (A) Time course of dose dependent binding of FITC-labeled, fixed GC to
immature DCs as analyzed by flow cytometry. GC were incubated for indicated time points at indicated bacteria:DC ratios. Binding was significantly
different for all phenotypes (P,0.05), except for the difference in binding of variants C and D after 15 minutes. (B) Binding and phagocytosis of FITC-
labeled, fixed GC to immature DCs was measured by flow cytometry. GC were incubated for 1 hour at indicated bacteria:DC ratios. Binding and
phagocytosis was significantly different for all phenotypes (P,0.05). (C) Phagocytosis of fixed GC (1 hour at indicated bacteria:DC ratios) can be
blocked by the addition of the actin-polymerization inhibitor Cytochalasin D (10 mM). Depicted are the average+SD of triplicates. Cyt D, cytochalasin
D (D) Dose dependent binding of FITC-labeled, live GC to immature DCs as analyzed by flow cytometry. GC were incubated for 1.5 hours at indicated
bacteria:DC ratios. (E) Binding of both fixed (left) and live (right) GC phenotypes A and C (1.5 hours at a bacteria:DC ratio of 20:1 for fixed and 10:1 for
live GC) to DCs is blocked by 10 mM EGTA. Binding of GC variant C but not A to DCs is inhibited by 100 mM of GalNAc. Depicted are the average+SD
of three independent donors for the fixed GC and the average of two independent donors for the live GC. Significant differences: * P,0.05,
** P,0.01, *** P,0.001.
doi:10.1371/journal.ppat.1000625.g002
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Figure 3. The C-type lectin MGL is a receptor for N. gonorrhoeae phenotype C. (A) Dose-dependent binding of MGL-Fc to coated GC.
Depicted is the average6SD of triplicates. (B) MGL-Fc binding to GC phenotype C can be blocked by 100 mM of EGTA, 20 mg/ml of anti-MGL
antibodies and the addition of free GalNAc monosaccharides (100 mM). GC were coated at 2.106 bacteria/well and MGL-Fc binding was determined
by an ELISA-based assay. Depicted is the average6SD of triplicates. (C) MGL-Fc binding to purified LOS from phenotype C can be blocked by 100 mM
of EGTA, 20 mg/ml of anti-MGL antibodies and the addition of free GalNAc monosaccharides (100 mM). GC LOS was coated at a concentration of
10 mg/ml and MGL-Fc binding was determined by an ELISA-based assay. Depicted is the average6SD of triplicates. (D) Expression of MGL on parental
and MGL-transfected CHO cells. Open histograms represent the isotype control and filled histograms represent the MGL staining. (E) CHO-MGL
transfectants were incubated with FITC-labeled GC at indicated bacteria to CHO-MGL ratios for 30 minutes at 37uC and analyzed by flow cytometry.
(F) Binding of FITC-labeled GC to CHO and CHO-MGL cells (30 minutes at a bacteria:CHO-MGL ratio of 20:1) was determined by flow cytometry in the
presence or absence of EGTA, anti-MGL antibodies or free GalNAc monosaccharides. Depicted is the average6SD of triplicates. (G) Expression of MGL
and DC-SIGN on immature monocyte-derived DCs. Open histograms represent the isotype control and filled histograms represent the MGL and DC-
SIGN staining. (H) Binding of FITC-labeled GC phenotype C (1.5 hours at a bacteria:DC ratio of 20:1) to DCs is blocked by an anti-MGL antibody.
Binding of GC variant A to DCs is blocked by an anti-DC-SIGN antibody (AZN-D1) and by the DC-SIGN specific ligand mannan (25 mg/ml). Depicted is
the average6SD of triplicates. All results are representative of three independent experiments. Significant differences: * P,0.05, ** P,0.01,
*** P,0.001.
doi:10.1371/journal.ppat.1000625.g003
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Neisseria gonorrhoeae modulates DC cytokine profiles
Having established that both MGL and DC-SIGN are present at
the site of infection, we investigated the functional consequences of
the N. gonorrhoeae-DC interaction. Immature DCs were incubated
with the different unlabeled fixed (to prevent bacterial overgrowth)
GC phenotypes and analyzed for expression of maturation markers
and secretion of pro- and anti-inflammatory cytokines. All GC
strains were potent inducers of DC maturation as visualized by the
increased expression levels of CD80, CD83 and CD86 even at very
low bacteria to DC ratios (Figure 5), suggesting that LOS variation
does not affect the expression of DC maturation markers.
Strikingly, cytokine secretion was influenced by variation of
LOS. Immature DCs pulsed overnight with GC at a bacteria:DC
ratio of 100:1 produced extremely high levels of IL-10, IL-12p70,
IL-6, IL-8 and TNFa (Figure 6A). IL-10 production was only
significantly decreased in DCs incubated with GC phenotype C
compared to DCs incubated with GC variant A (Figure 6A). The
slight increase in IL-12p70 secretion by DCs pulsed GC
phenotype C was not statistically significant. IL-6, IL-8 and TNFa
levels remained unchanged (Figure 6A). We could not detect any
IL-17 production by GC-stimulated DCs, eliminating the
possibility that the GC aspecifically bind the antibodies used in
this assay (data not shown). The observed effects were not due to
differences in TLR2 or TLR4 triggering, as all strains induced
equal TLR activation in HEK-TLR2 or HEK-TLR4 reporter
cells (Figure 6B). Thus, variation of terminal glycans on GC LOS
directly affects cytokine secretion by DCs, potentially modifying
the induction of adaptive immune responses.
Induction of T helper responses by GC-matured DC
DCs play a key role in shaping adaptive immunity. Upon
pathogen encounter DC undergo a phenotypic transformation
termed maturation, followed by migration to the lymph node,
where the mature DCs prime naı¨ve T cells to become effector T
cells. The multitude of innate signals received from the pathogen
largely determines the nature of the adaptive T cell response. To
mimic this, we primed DCs with the different fixed GC variants
and subsequently co-cultured these DCs with naive T cells to
analyze T helper (Th) cell differentiation. Th1 and Th2
polarization was defined by the relative shifts in IL-4 (for Th2)
and IFNc (for Th1)-producing T cells. In this assay, relative to the
LPS-matured DC, Poly I:C and E. coli LPS supplemented with
PGE2 served as controls for Th1 and Th2 skewing, respectively.
Interestingly, DCs pulsed with GC phenotype C had an increased
ability to functionally polarize Th2 cells (Figure 7A), irrespective
whether the donors were more prone to induce Th1 (donor 2) or
Th2-type responses (donor 1). Even though the number of Th1
cells remained unchanged, in donor 2 an increase in Th2 cells was
observed using DCs stimulated with variant C. DCs incubated
with GC phenotype B predominantly generated Th1 T cells,
whereas T cells activated by DCs co-cultured with GC variant A
displayed an intermediate phenotype (Figure 7A).
Human DCs readily promote the development of Th17 cells
from memory T cells [28]. Th17 responses are important for
clearance of bacterial infections and are initiated after activation of
the intracellular pattern recognition receptors NOD2 or dectin-1
[29,30]. Natural ligands for NOD2 and dectin-1 comprise
peptidoglycan (PGN) and curdlan, respectively. PGN fragments
are also released during GC growth suggesting that in vivo N.
gonorrhoeae might also induce Th17-type immunity [31]. Compared
to the positive controls S. aureus PGN and curdlan, all GC variants
triggered robust Th17 differentiation in human T cells as
measured by the specific IL-17 production in these cells. In both
donors, the strongest Th17 polarization was observed with the
Figure 4. MGL and DC-SIGN are present at the site of GC entry. Expression of MGL (red) and DC-SIGN (green) in cryosections of human
ectocervix (A, left) and penile urethral tissue (B, left). Nuclei are stained with Hoechst (blue, right pictures). MGL positive cells in the epithelial layer are
indicated by the white arrows. Original magnification 2006. E, epithelium; S, sup-epithelial tissue.
doi:10.1371/journal.ppat.1000625.g004
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DCs incubated with GC phenotype C (Figure 7B). Together, our
data indicate that N. gonorrhoeae has the potential to actively modify
its LOS to manipulate DC-induced adaptive immune responses.
Discussion
The lack of a suitable non-primate animal model for Neisseria
gonorrhoeae (gonococci, GC) has hampered our knowledge on the
immunological events following infection with this obligate human
pathogen. By relying on in vitro epithelial cell culture models the
mechanisms of GC entry and invasion have been extensively
studied (reviewed in [32]). Here, we provide more insight into how
the human immune system and specifically dendritic cells deal
with naturally occurring LOS variants of N. gonorrhoeae. DCs are in
general the first cells of the immune system to encounter local
pathogens and they are instrumental in the induction of
subsequent innate and adaptive immune responses [7]. Our
results indicate that GC can target different C-type lectin receptors
on DCs by varying its LOS. We confirm previous results from
Zhang et al. which demonstrate the interaction of DC-SIGN with
N. gonorrhoeae variant A [20,21]. C-type lectins and especially DC-
SIGN have already been shown to interact with a vast array of
pathogens including several bacterial species [33–36]. Known
pathogens that engage MGL include the helminth parasite
Schistosoma mansoni and several members of the filoviridae family
[25,37]. Yet, no bacterial ligands have been described so far for
the human MGL receptor. C-type lectins constitute the main
receptors for GC on DCs, as only some residual binding to DC
was observed for GC phenotype B or the variants A and C after
blocking MGL and DC-SIGN function respectively, to DCs.
Other known receptors for GC surface factors such as pili and
Opa proteins on DCs include members of the CD66 family, CD46
and CR3 [4,38–40]. Targeting of these receptors may have
additional immunomodulatory effects. We used non-piliated GC
that lack detectable Opa protein expression to specifically dissect
the DC-LOS interaction. Opa-deficient GC have previously been
reported to still maximally adhere to human DCs [21]. We also
considered siglec receptors that specifically recognize a2,3-
sialylated LOS [41] as potential receptors. However, these
receptors are mainly present on macrophages and mature DC
and low to absent on immature DC [42,43].
Our results suggest that based on the differential receptor
engagement, GC may influence subsequent immune responses
initiated by DCs through variation of their LOS, a feature never
Figure 5. GC LOS variation does not influence expression of DC maturation markers. Immature DC were incubated with unlabeled fixed
GC at a bacteria:DC ratio of 100:1 (A) or in a dose-dependent range (B). After 16 hours of stimulation the expression of DC maturation markers CD80,
CD83 and CD86 was measured by flow cytometry. The dashed line indicates the expression level in immature DCs. One out of four independent
donors is shown.
doi:10.1371/journal.ppat.1000625.g005
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Figure 6. DCs incubated with GC variant C secrete significantly less IL-10 compared to DCs stimulated with variant A. (A) Immature
DCs were incubated with unlabeled fixed GC at a bacteria:DC ratio of 100:1 for 16 hours. Supernatants were harvested and cytokine production was
measured by ELISA. E. coli LPS (10 ng/ml) was included as a positive control. The box plots represent the combined data of six independent donors.
* indicates a significant difference in IL-10 production by DCs stimulated with GC phenotype C compared to DCs stimulated with GC phenotype A
(p,0.05). (B) All phenotypes activate TLR2 and TLR4 equally as measured by IL-8 release by HEK-TLR2 and HEK-TLR4/MD2 reporter cells. Depicted is
the average6SD of triplicates. Dashed line indicates the basal IL-8 levels of unstimulated cells.
doi:10.1371/journal.ppat.1000625.g006
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before reported forN. gonorrhoeae. C-type lectins are already implicated
in homeostatic control by DC through the binding and capture of
self-glycoproteins [44]. In the steady state, the antigen-handling
capacity of C-type lectins on DCs can maintain peripheral tolerance
through deletion of self-reactive T cells and the generation of
regulatory T cells [45]. As several GC LOS glycan structures mimic
human membrane glycosphingolipids, it is tempting to speculate that
GC exploit the regulatory pathways induced by these C-type lectins
in favor of their own survival. Protective immune responses to N.
gonorrhoeae are generally T helper 1 (Th1)-type in nature, leading to the
production of complement-fixing antibodies, as patients with defects
in the complement pathways often suffer from recurrent and
disseminated gonoccocal infections [46]. Here, we show that GC
phenotype C induces phenotypic changes in DCs leading to
alterations in the cytokines secreted by the matured DCs and more
pronounced Th2 and Th17 responses. The combined expression of
both GalNAc and galactose on the terminal end of LOS phenotype C
(as shown in Figure 1C and [22,23]), indicates that our results may
even underestimate the effects a terminal GalNac residue could have
on human DCs. To our knowledge induction of Th17 cells by N.
gonorrhoeae has not previously been reported, but the related bacterium
N. meningitidis also instructs the polarization of Th17-type T cells [28].
Th17-type immunity has been shown to facilitate the destruction and
clearance of fungi and extracellular bacteria [47]. Skewing towards
Th2 could result in a decreased production of complement-fixing
antibodies, whichmay delay bacterial eradication by the host defense.
GC have developed a variety of mechanisms to avoid complement-
mediated killing, the so-called serum-resistance. Stable serum
resistance can be mediated through sialylation of the LOS
oligosaccharide and through binding of the porin protein to the
complement regulatory protein factor H [48]. We suggest that
deviation towards unfavourable T helper responses may be another,
more indirect gonococcal immune evasion strategy.
We observed significantly increased IL-10 production by DCs
stimulated with GC phenotype A. Several bacterial species,
including Mycobacterium tuberculosis and Helicobacter pylori, target the
Figure 7. GC are potent inducers of human CD4+ T helper responses. (A) T helper responses induced by GC phenotype C-stimulated DCs are
skewed towards Th2. Naı¨ve CD4+ T cells were cocultured with DCs stimulated with unlabeled fixed GC at a bacteria:DC ratio of 100:1. After 14 days
intracellular IL-4 and IFNc production by the T cells was analyzed on a single cell basis by flow cytometry. E. coli LPS (100 ng/ml), LPS+PGE2 (100 ng/ml
and 10 mg/ml respectively) and Poly I:C (20 mg/ml) were included as positive controls of mixed, Th2 and Th1 skewing, respectively. Results of two
representative donors out of five are shown. (B) DCs stimulated with GC phenotype C induce slightly stronger Th17 responses. CD4+ T cells were
cocultured with DCs stimulated with unlabeled fixed GC at a bacteria:DC ratio of 100:1. After 4 days IL-17 production was measured in the supernatant
by ELISA. Poly I:C was used as a negative control, peptidoglycan (PGN, 10 mg/ml) and the b-glucan curdlan (10 mg/ml) were included as positive
controls. Results of two independent donors are shown.
doi:10.1371/journal.ppat.1000625.g007
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C-type lectin DC-SIGN to selectively induce IL-10 secretion
[33,36]. Strikingly, these pathogens all inflict chronic infections,
suggesting that the IL-10 may be important in this process, by
creating an environment that supports pathogen survival while
limiting tissue pathology. Therefore, LOS structures containing
the terminal GlcNAc of the variant A glycan could aid the
bacterium to establish latent infection. It has been suggested that
only variation in lipid A moieties can influence proinflammatory
cytokine production in human cell lines and primary monocytes
[49,50]. Yet, our results indicate that also the carbohydrate
component of LOS can directly modulate DC responses, as the
TLR2 and TLR4 activating potential was equal for all GC
variants. This apparent discrepancy could be explained by C-type
lectin expression levels, which are high on DCs and low to absent
in human monocytes and epithelial or monocytic cell lines. Hence,
C-type lectin-mediated signals would only be able to affect
cytokine secretion in human DCs.
The high rate of re-infection suggests that N. gonorrhoeae possesses
several strategies to actively suppress host adaptive immune
reactions; however these mechanisms are only beginning to be
unraveled. GC expressed Opa proteins can directly suppress T cell
receptor signaling through engagement of coinhibitory CD66a/
CEACAM1 receptor, thereby raising the threshold for CD4+ T
cell activation and proliferation to activating stimuli such as IL-2
or CD3 ligation [51,52]. The CD66a/CEACAM1-Opa interac-
tion also impedes antibody production by promoting cell death in
human B cells [53]. Overall, humoral immune responses to N.
gonorrhoeae are relatively modest and our results suggest that in
addition to killing B cells, GC may also be capable of influencing T
helper responses to alter the isotype of the elicited antibodies.
Recently, an influx of regulatory T cells was observed in a newly
refined model of N. gonorrhoeae infection in 17b-estradiol treated
mice [54,55]. However, regulatory T cells were only detected at
relatively late time points, suggesting that these suppressive T cells
were newly induced or expanded shortly after inoculation of the
bacteria. Next to immunity, DCs have also been shown to directly
contribute to the expansion and differentiation of regulatory T
cells through the expression of inhibitory molecules belonging to
the B7 or ILT family or through the secretion of suppressive
cytokines such as IL-10 [56]. These so-called tolerogenic IL-
10DCs can generate antigen-specific regulatory T cells [57].
Strikingly, DCs stimulated with GC and especially GC phenotype
A, secrete extremely high levels of IL-10. We speculate that the
high IL-10 production might facilitate the formation of regulatory
T cells, which could, during ongoing infection, limit pathogen-
specific immune responses and thus contribute to successful
colonization of the bacteria.
Based on our results, it can be argued that variation of the GC
LOS glycan structures could have a functional relevance for
bacterial survival within an infected individual. Different terminal
glycans can target different C-type lectin receptors on human DCs
thereby modifying DC function and possibly also host immune
responses. LOS of variant A induces high IL-10 secretion by the
DC, which might aid the outgrowth of regulatory T cells. Our data
indicates that the terminal GalNAc residue, as found on LOS of GC
phenotype C, skews T helper differentiation towards unfavorable
Th2-type responses. This scenario of events collaborates the early
findings of Schneider et al. that showed that active disease is
associated with expression of longer LOS variants containing
terminal GalNAc residues [19]. Modulation of the terminal
galactose might therefore be important for bacterial pathogenesis
in the host. Indeed, in vivo the terminal galactose is usually capped by
either a GalNAc, which, based on our studies, might modulate DC
function, or a sialic acid moiety, which confers serum-resistance.
In conclusion, our results extend the plethora of immune
evasion mechanisms that have evolved within the N. gonorrhoeae
species. The strategic bacterial intervention operating at multiple
levels of the human immune system, including DCs, likely explains
the maintained persistence of this bacterium in its obligatory
human host.
Materials and Methods
Bacterial strains
Neisseria gonorrhoeae strain F62 and its derivatives D3 and I3
(structures shown in Figure 1) were generously provided by E.C.
Gotschlich (Rockefeller University, New York, USA) [15]. Non-
piliated strains were grown on GC agar base (Difco, Becton
Diskinson France) supplemented with 1% Vitox (Oxoid, Basing-
stoke, UK) at 37uC in an atmosphere of 5% CO2 at 37uC. When
appropriate, bacteria were inactivated in 0.5% paraformaldehyde
in phosphate buffered saline (PBS) for 15 minutes followed by
thorough washing in RPMI 1640 medium without phenol red
(Invitrogen, Carlsbad, CA, USA). FITC-labeled bacteria were
prepared by incubation of 2.109 bacteria with 0.5 mg/ml of FITC
(Sigma-Aldrich, St. Louis, MO, USA) for 20 minutes at 37uC
followed by extensive washing. Bacterial suspensions with an
optical density at 540 nm of 1, corresponding to 109 bacteria/ml,
were prepared in RPMI 1640 medium without phenol red. All
bacteria were equally FITC-labeled as determined by FACS
(Figure S1).
Cells
Human immature monocyte-derived DCs were cultured for 4–7
days in RPMI 1640 medium (Invitrogen) containing 10% Fetal
Calf Serum from monocytes obtained from buffy coats of healthy
donors (Sanquin, Amsterdam, the Netherlands) in the presence of
IL-4 and GM-CSF (500 U/ml and 800 U/ml respectively,
Biosource, Camarillo, CA, USA). CHO cells were maintained in
RPMI 1640 medium containing 10% Fetal Calf Serum. Stable
CHO-MGL and CHO-DC-SIGN transfectants were regularly
selected using 1 mg/ml Geneticin (Invitrogen). To check for C-
type lectin expression, cells were incubated with primary antibody
(AZN-D1 (DC-SIGN [58]), 18E4 (MGL [27]), 5 mg/ml), followed
by staining with a secondary FITC-labeled anti-mouse antibody
(Zymed, San Francisco, CA) and analyzed on a FACScan (BD
Biosciences, San Diego, CA). For analysis of DC maturation, DCs
were incubated for 30 minutes at 4uC with phycoerythrin-
conjugated antibodies to CD83 (Beckman Coulter, Fullerton,
CA), CD80 and CD86 (both from BD Biosciences) and analyzed
on a FACScan.
LOS isolation, electrophoresis, and Western blotting
The LOS phenotype of the GC was confirmed by tricine SDS-
PAGE of proteinase K-treated bacteria and silverstaining as
described [18]. Purified LOS was prepared as described [59].
Expression of Opa proteins was determined by SDS-PAGE and
Western blotting using the Opa protein-specific monoclonal
antibody 4B12.CII as previously described [60]. The gonococcal
strain VP1 expressing Opa protein served as a positive control.
Cellular binding and internalization assays
Binding experiments were conducted by incubating immature
DCs, CHO parental or CHO transfectants with FITC-labeled GC
at indicated bacteria:DC ratios for indicated time points at 37uC in
RPMI/0.5% BSA. Binding was analyzed by flow cytometry and is
represented as the percentage of cells that have bound the
fluorescent bacteria. Phagocytosis was determined in the presence
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of a 1:10 dilution of Trypan Blue (0.4%) to quench the
fluorescence of the extracellular bacteria [21]. Specificity of
binding was assessed in the presence or absence of EGTA
(10 mM), blocking antibodies (20 mg/ml), mannan (25 mg/ml,
Sigma-Aldrich) or free GalNAc monosaccharides (100 mM).
When appropriate, DCs were pretreated with 10 mMCytochalasin
D (to block actin polymerization, Sigma-Aldrich) for 30 minutes at
37uC. Cytochalasin D was present during the entire assay.
MGL-Fc binding assays
GC or purified LOS were coated in PBS at indicated
concentrations on NUNC maxisorb plates (Roskilde, Denmark)
overnight at room temperature. Plates were blocked with 1% BSA
and MGL-Fc was added (0.5 mg/ml) for 2 hours at room
temperature in the presence or absence of 10 mM EGTA,
100 mM free GalNAc monosaccharides or 20 mg/ml mAbs.
Binding was detected using a peroxidase-labeled anti-human
IgG-Fc antibody (Jackson, West grove, PA). MGL-Fc and DCIR-
Fc control, comprising of the extracellular domains of MGL and
DCIR fused to the human IgG1 Fc tail, were generated as
previously described [25,34]. Fc-proteins were purified from the
supernatant of CHO-transfectants using protA columns.
Immunohistochemistry
Cryosections of healthy human tissues (7 m) were fixed with
100% aceton and stained with primary antibodies to DC-SIGN
and MGL (10 mg/ml) for 1 hour at 37uC. Sections were
counterstained with isotype-specific Alexa488- or Alexa594-
labeled anti-mouse antibodies (Molecular probes, Carlsbad, CA).
Nuclei were visualized using Hoechst.
Cytokine measurements
DC supernatants were harvested 24 hours after DC activation
and frozen at 280uC until analysis. Cytokines were measured by
ELISA with CytoSetsTM ELISA kits (Biosource), according to the
manufacturer’s protocol. Human IL-12p70 detection was deter-
mined as previously described [61].
TLR2 and 4 reporter assay
HEK293 cells stably expressing TLR2 or TLR4 and MD2 [62],
a gift from D. Golenbock (University of Massachusetts Medical
School, Worcester, USA), were stimulated with the GC at
indicated bacteria:cell ratios. After 24 hours, supernatants were
analyzed for IL-8 production by ELISA according to the
manufacturer’s guidelines (Biosource/Invitrogen).
DC driven polarization of T helper responses
The skewing of T helper 1 (Th1) and Th2 responses was
determined as previously described [33]. Briefly, immature
monocyte-derived DCs were stimulated with unlabeled formal-
dehyde fixed GC at a bacteria:DC ratio of 100:1. E. coli LPS
(100 ng/ml, Sigma-Aldrich), LPS+PGE2 (100 ng/ml and 10 mg/
ml respectively, Sigma-Aldrich) and Poly I:C (20 mg/ml, Invivo-
gen, San Diego, CA) were included as positive controls of mixed,
Th2 and Th1 skewing, respectively. After 2 days, DCs were
washed and incubated with allogeneic naı¨ve CD4+ T cells (ratio
1:10). In parallel, DCs were analyzed for maturation markers by
flow cytometry. Untouched naı¨ve CD4+ T cells were isolated
using MACS isolation from PBMC by depleting all non-CD4+
and memory T cells (Miltenyi Biotec, Bergisch Gladbach,
Germany). At day 5, IL-2 (10 U/ml) was added. At day 12 or
13, quiescent T cells were re-stimulated with 30 ng/ml PMA and
1 mg/ml ionomycin (both Sigma-Aldrich) for 6 h. After 1 hour
10 mg/ml Brefeldin A (Sigma-Aldrich) was added to the T cells.
Single cell production of IL-4 and IFNc was determined by
intracellular flow cytometric analysis. Cells were fixed in 2%
PFA, permeabilized with 0.5% saponin (Sigma-Aldrich) and
stained with anti-human IFNc-FITC and anti-human IL-4-PE
(BD Biosciences).
T helper 17 (Th17) responses were determined as previously
described [28]. Briefly, immature monocyte-derived DCs were
stimulated with unlabeled formaldehyde fixed GC at a bacter-
ia:DC ratio of 100:1. Poly I:C (20 mg/ml) was used as a negative
control, Staphylococcus aureus peptidoglycan (PGN, 10 mg/ml,
Sigma-Aldrich) and the b-glucan curdlan (Alcaligenes faecalis,
10 mg/ml, Sigma-Aldrich) were included as positive controls for
Th17 skewing. After 24 hours DCs were washed and incubated
with allogeneic memory CD4+ T cells (ratio 1:10). Untouched
memory CD4+ T cells were isolated using MACS isolation from
PBMC by depleting all non-CD4+ and naive T cells (Miltenyi
Biotec, Bergisch Gladbach, Germany). At day 5, IL-17
production by the T cells was measured by ELISA according
to the manufacturer’s protocol (eBioscience, San Diego, CA).
Statistical analysis
Data were analyzed for statistical significance using a two-tailed
paired Student t-test. Cytokine levels were compared using
ANOVA followed by Bonferroni’s Multiple Comparison Test.
All p-values,0.05 were considered significant.
Accession numbers
MGL: CD301/CLEC10A, GenBank/EMBL NM_006344. DC-
SIGN: CD209, GenBank/EMBL AF290886.
Supporting Information
Figure S1 Representative FITC-labeling of GC. Bacteria were
labeled with 0.5 mg/ml of FITC for 20 minutes at 37uC followed
by extensive washing and analysis by flow cytometry. Open
histograms represent unlabeled bacteria and filled histograms
represent FITC-labeled baceria.
Found at: doi:10.1371/journal.ppat.1000625.s001 (0.10 MB TIF)
Figure S2 Differential binding of GC glycosylation variants to
DCs. Binding and phagocytosis of FITC-labeled, fixed GC to
immature DCs of donor B (A) and donor C (B) was measured by
flow cytometry. GC were incubated for 1 hour at indicated
bacteria:DC ratios. Phenotype A was significantly different from
variants B and C in both binding (P,0.01) and phagocytosis
(P,0.05). Phenotype B was significantly different from phenotype
C in binding (P,0.05) but not phagocytosis.
Found at: doi:10.1371/journal.ppat.1000625.s002 (0.30 MB TIF)
Acknowledgments
We would like to thank E. Gotschlich for providing the stable GC mutant
strains and D. Golebock for the HEK-TLR4/MD2 transfectants and M.
Litjens for her assistance with the fluorescence microscopy.
Author Contributions
Conceived and designed the experiments: SJvV LS JPMvP YvK.
Performed the experiments: SJvV LS SCMB MMV CSB MD. Analyzed
the data: SJvV. Contributed reagents/materials/analysis tools: LS JAAB
JPMvP. Wrote the paper: SJvV JPMvP YvK.
DC Modulation by Neisseria gonorrhoeae
PLoS Pathogens | www.plospathogens.org 11 October 2009 | Volume 5 | Issue 10 | e1000625
References
1. Gerbase AC, Rowley JT, Heymann DH, Berkley SF, Piot P (1998) Global
prevalence and incidence estimates of selected curable STDs. Sex Transm Infect
74 Suppl 1: S12–S16.
2. Hillis SD, Nakashima A, Marchbanks PA, Addiss DG, Davis JP (1994) Risk
factors for recurrent Chlamydia trachomatis infections in women. Am J Obstet
Gynecol 170: 801–806.
3. Cohen MS (1998) Sexually transmitted diseases enhance HIV transmission: no
longer a hypothesis. Lancet 351 Suppl 3: 5–7.
4. Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB (1997) Membrane
cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic
Neisseria. Mol Microbiol 25: 639–647.
5. Rechner C, Kuhlewein C, Muller A, Schild H, Rudel T (2007) Host
glycoprotein Gp96 and scavenger receptor SREC interact with PorB of
disseminating Neisseria gonorrhoeae in an epithelial invasion pathway. Cell Host
Microbe 2: 393–403.
6. Hauck CR, Meyer TF (2003) ‘Small’ talk: Opa proteins as mediators of Neisseria-
host-cell communication. Curr Opin Microbiol 6: 43–49.
7. Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells:
versatile controllers of the immune system. Nat Med 13: 1155–1159.
8. Villadangos JA, Schnorrer P (2007) Intrinsic and cooperative antigen-presenting
functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7: 543–555.
9. Figdor CG, van Kooyk Y, Adema GJ (2002) C-type lectin receptors on dendritic
cells and Langerhans cells. Nature Rev Immunol 2: 77–84.
10. West AP, Koblansky AA, Ghosh S (2006) Recognition and Signaling by Toll-
Like Receptors. Annu Rev Cell Dev Biol 22: 409–437.
11. Danaher RJ, Levin JC, Arking D, Burch CL, Sandlin R, et al. (1995) Genetic
basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation. J Bacteriol
177: 7275–7279.
12. Apicella MA, Shero M, Jarvis GA, Griffiss JM, Mandrell RE, et al. (1987)
Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligo-
saccharide. Infect Immun 55: 1755–1761.
13. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM (2003)
Collaborative induction of inflammatory responses by dectin-1 and Toll-like
receptor 2. J Exp Med 197: 1107–1117.
14. Gringhuis SI, den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, et al.
(2007) C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via
Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-kappaB.
Immunity 26: 605–616.
15. Gotschlich EC (1994) Genetic locus for the biosynthesis of the variable portion of
Neisseria gonorrhoeae lipooligosaccharide. J Exp Med 180: 2181–2190.
16. Shafer WM, Datta A, Kolli VS, Rahman MM, Balthazar JT, et al. (2002) Phase
variable changes in genes lgtA and lgtC within the lgtABCDE operon of Neisseria
gonorrhoeae can modulate gonococcal susceptibility to normal human serum.
J Endotoxin Res 8: 47–58.
17. Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, et al. (1998) A
novel sialic acid binding site on factor H mediates serum resistance of sialylated
Neisseria gonorrhoeae. J Exp Med 187: 743–752.
18. van Putten JP (1993) Phase variation of lipopolysaccharide directs interconver-
sion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J
12: 4043–4051.
19. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, Zahos KM, et al. (1991)
Expression of paragloboside-like lipooligosaccharides may be a necessary
component of gonococcal pathogenesis in men. J Exp Med 174: 1601–1605.
20. Zhang P, Snyder S, Feng P, Azadi P, Zhang S, et al. (2006) Role of N-
acetylglucosamine within core lipopolysaccharide of several species of gram-
negative bacteria in targeting the DC-SIGN (CD209). J Immunol 177:
4002–4011.
21. Zhang P, Schwartz O, Pantelic M, Li G, Knazze Q, et al. (2006) DC-SIGN
(CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosacchar-
ide variation. J Leukoc Biol 79: 731–738.
22. Yamasaki R, Bacon BE, Nasholds W, Schneider H, Griffiss JM (1991) Structural
determination of oligosaccharides derived from lipooligosaccharide of Neisseria
gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods.
Biochemistry 30: 10566–10575.
23. Yamasaki R, Nasholds W, Schneider H, Apicella MA (1991) Epitope expression
and partial structural characterization of F62 lipooligosaccharide (LOS) of
Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-
reducing termini of the LOS components. Mol Immunol 28: 1233–1242.
24. Harvey HA, Jennings MP, Campbell CA, Williams R, Apicella MA (2001)
Receptor-mediated endocytosis of Neisseria gonorrhoeae into primary human
urethral epithelial cells: the role of the asialoglycoprotein receptor. Mol
Microbiol 42: 659–672.
25. van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk B, et al.
(2005) Carbohydrate profiling reveals a distinctive role for the C-type lectin
MGL in the recognition of helminth parasites and tumor antigens by dendritic
cells. Int Immunol 17: 661–669.
26. Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF,
et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that
enhances trans-infection of T cells. Cell 100: 587–597.
27. van Vliet SJ, van Liempt E, Geijtenbeek TB, van Kooyk Y (2006) Differential
regulation of C-type lectin expression on tolerogenic dendritic cell subsets.
Immunobiology 211: 577–585.
28. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW,
et al. (2007) Stimulation of the intracellular bacterial sensor NOD2 programs
dendritic cells to promote interleukin-17 production in human memory T cells.
Immunity 27: 660–669.
29. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, et al. (2005) Divergent
roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med
202: 761–769.
30. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, et al.
(2007) Syk- and CARD9-dependent coupling of innate immunity to the
induction of T helper cells that produce interleukin 17. Nat Immunol 8:
630–638.
31. Melly MA, McGee ZA, Rosenthal RS (1984) Ability of monomeric
peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-
tube mucosa. J Infect Dis 149: 378–386.
32. Merz AJ, So M (2000) Interactions of pathogenic neisseriae with epithelial cell
membranes. Annu Rev Cell Dev Biol 16: 423–457.
33. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, et al.
(2004) Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance
through phase-variable interaction between lipopolysaccharide and DC-SIGN.
J Exp Med 200: 979–990.
34. Steeghs L, van Vliet SJ, Uronen-Hansson H, van Mourik A, Engering A, et al.
(2006) Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN
and modulates dendritic cell function. Cell Microbiol 8: 316–325.
35. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C
(2006) Myeloid C-type lectins in innate immunity. Nat Immunol 7: 1258–1265.
36. Geijtenbeek TB, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vanden-
broucke-Grauls CM, et al. (2003) Mycobacteria Target DC-SIGN to Suppress
Dendritic Cell Function. J Exp Med 197: 7–17.
37. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, et al. (2004) Human
macrophage C-type lectin specific for galactose and N-acetylgalactosamine
promotes filovirus entry. J Virol 78: 2943–2947.
38. Edwards JL, Brown EJ, Ault KA, Apicella MA (2001) The role of complement
receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia. Cell
Microbiol 3: 611–622.
39. Virji M, Watt SM, Barker S, Makepeace K, Doyonnas R (1996) The N-domain
of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria
meningitidis and Neisseria gonorrhoeae. Mol Microbiol 22: 929–939.
40. Chen T, Grunert F, Medina-Marino A, Gotschlich EC (1997) Several
carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity
proteins. J Exp Med 185: 1557–1564.
41. Jones C, Virji M, Crocker PR (2003) Recognition of sialylated meningococcal
lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced
bacterial uptake. Mol Microbiol 49: 1213–1225.
42. Bax M, Garcia-Vallejo JJ, Jang-Lee J, North SJ, Gilmartin TJ, et al. (2007)
Dendritic cell maturation results in pronounced changes in glycan expression
affecting recognition by siglecs and galectins. J Immunol 179: 8216–8224.
43. O’Reilly MK, Paulson JC (2009) Siglecs as targets for therapy in immune-cell-
mediated disease. Trends Pharmacol Sci 30: 240–248.
44. Geijtenbeek TB, van Vliet SJ, Engering A, ’t Hart BA, van Kooyk Y (2004) Self-
and Nonself-Recognition by C-Type Lectins on Dendritic Cells. Annu Rev
Immunol 22: 33–54.
45. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, et al. (2002)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in
the steady state leads to antigen presentation on major histocompatibility
complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196:
1627–1638.
46. Densen P (1989) Interaction of complement with Neisseria meningitidis and Neisseria
gonorrhoeae. Clin Microbiol Rev 2 Suppl: S11–S17.
47. Mills KH (2008) Induction, function and regulation of IL-17-producing T cells.
Eur J Immunol 38: 2636–2649.
48. Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, et al. (2008) Human factor
H interacts selectively with Neisseria gonorrhoeae and results in species-specific
complement evasion. J Immunol 180: 3426–3435.
49. Pridmore AC, Jarvis GA, John CM, Jack DL, Dower SK, et al. (2003) Activation
of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of
capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS
from different strains. Infect Immun 71: 3901–3908.
50. Patrone JB, Stein DC (2007) Effect of gonococcal lipooligosaccharide variation
on human monocytic cytokine profile. BMC Microbiol 7: 7.
51. Lee HS, Ostrowski MA, Gray-Owen SD (2008) CEACAM1 dynamics during
Neisseria gonorrhoeae suppression of CD4+ T lymphocyte activation. J Immunol
180: 6827–6835.
52. Boulton IC, Gray-Owen SD (2002) Neisserial binding to CEACAM1 arrests the
activation and proliferation of CD4+ T lymphocytes. Nat Immunol 3: 229–236.
53. Pantelic M, Kim YJ, Bolland S, Chen I, Shively J, et al. (2005) Neisseria gonorrhoeae
kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-
expressing human B cells and inhibits antibody production. Infect Immun 73:
4171–4179.
54. Imarai M, Candia E, Rodriguez-Tirado C, Tognarelli J, Pardo M, et al. (2008)
Regulatory T cells are locally induced during intravaginal infection of mice with
Neisseria gonorrhoeae. Infect Immun.
DC Modulation by Neisseria gonorrhoeae
PLoS Pathogens | www.plospathogens.org 12 October 2009 | Volume 5 | Issue 10 | e1000625
55. Song W, Condron S, Mocca BT, Veit SJ, Hill D, et al. (2008) Local and humoral
immune responses against primary and repeat Neisseria gonorrhoeae genital tract
infections of 17beta-estradiol-treated mice. Vaccine 26: 5741–5751.
56. Adler HS, Steinbrink K (2007) Tolerogenic dendritic cells in health and disease:
friend and foe! Eur J Dermatol 17: 476–491.
57. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH (1997) Induction of
tolerance by IL-10-treated dendritic cells. J Immunol 159: 4772–4780.
58. Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ,
et al. (2000) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3
receptor that supports primary immune responses. Cell 100: 575–85.
59. Keestra AM, van Putten JP (2008) Unique properties of the chicken TLR4/MD-
2 complex: selective lipopolysaccharide activation of the MyD88-dependent
pathway. J Immunol 181: 4354–4362.
60. Knepper B, Heuer I, Meyer TF, van Putten JP (1997) Differential response of
human monocytes to Neisseria gonorrhoeae variants expressing pili and opacity
proteins. Infect Immun 65: 4122–4129.
61. Snijders A, Hilkens CM, van der Pouw Kraan TC, Engel M, Aarden LA, et al.
(1996) Regulation of bioactive IL-12 production in lipopolysaccharide-
stimulated human monocytes is determined by the expression of the p35
subunit. J Immunol 156: 1207–1212.
62. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, et al. (2002)
Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the
toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the
initiation of signal transduction. J Biol Chem 277: 47834–47843.
DC Modulation by Neisseria gonorrhoeae
PLoS Pathogens | www.plospathogens.org 13 October 2009 | Volume 5 | Issue 10 | e1000625
